| Toy S Holland, OD | |
|
300 1st St N, Alabaster, AL 35007-8764 | |
| (205) 663-4932 | |
| (205) 663-2015 |
| Full Name | Toy S Holland |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 38 Years |
| Location | 300 1st St N, Alabaster, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831192384 | NPI | - | NPPES |
| 051519324 | Other | AL | BLUECROSSBLUESHIELD |
| 009939485 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | S603TA109 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Visionfirst Eye Center, Inc | 2769378777 | 9 |
News Archive
A group of white blood cells known as B cells, which play a key role in the human immune response, need a protein-targeting signal called mannose 6-phosphate (M6P) in order to proliferate, differentiate, and present immune cell-activating antigens, according to a study in The Journal of Cell Biology.
Continuing to drive innovation in endovascular aortic repair (EVAR), Medtronic, Inc., today announced the introduction of an imaging and visualization service for endovascular specialists who use the company's market-leading portfolio of stent grafts to treat aortic aneurysms. Aortic aneurysms affect more than one million people in the United States alone and can rupture with fatal consequences if left untreated.
New research shows that exposing a 3D human skin tissue model to extracts of medical device materials can detect the presence of sensitizers known to cause an allergic response on contact in some individuals. Conventional skin sensitization testing of medical devices relies on animal testing, whereas human skin models could replace animal methods, according to an article in the new journal Applied In Vitro Toxicology, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
SeraCare Life Sciences, a leading partner to global in vitro diagnostics manufacturers, today announced that it has signed a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute, part of the National Institutes of Health, to create reference materials and positive controls for cancer assays.
BrainScope Company, Inc. announced today that it is preparing for the introduction of the Ahead™ EU-100, a product in development to aid in the assessment of head injury, in the United Kingdom.
› Verified 5 days ago
| Provider Name | Visionfirst Eye Center, Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1629118286 PECOS PAC ID: 2769378777 Enrollment ID: O20040226000219 |
News Archive
A group of white blood cells known as B cells, which play a key role in the human immune response, need a protein-targeting signal called mannose 6-phosphate (M6P) in order to proliferate, differentiate, and present immune cell-activating antigens, according to a study in The Journal of Cell Biology.
Continuing to drive innovation in endovascular aortic repair (EVAR), Medtronic, Inc., today announced the introduction of an imaging and visualization service for endovascular specialists who use the company's market-leading portfolio of stent grafts to treat aortic aneurysms. Aortic aneurysms affect more than one million people in the United States alone and can rupture with fatal consequences if left untreated.
New research shows that exposing a 3D human skin tissue model to extracts of medical device materials can detect the presence of sensitizers known to cause an allergic response on contact in some individuals. Conventional skin sensitization testing of medical devices relies on animal testing, whereas human skin models could replace animal methods, according to an article in the new journal Applied In Vitro Toxicology, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
SeraCare Life Sciences, a leading partner to global in vitro diagnostics manufacturers, today announced that it has signed a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute, part of the National Institutes of Health, to create reference materials and positive controls for cancer assays.
BrainScope Company, Inc. announced today that it is preparing for the introduction of the Ahead™ EU-100, a product in development to aid in the assessment of head injury, in the United Kingdom.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Toy S Holland, OD 300 1st St N, Alabaster, AL 35007-8764 Ph: (205) 663-4932 | Toy S Holland, OD 300 1st St N, Alabaster, AL 35007-8764 Ph: (205) 663-4932 |
News Archive
A group of white blood cells known as B cells, which play a key role in the human immune response, need a protein-targeting signal called mannose 6-phosphate (M6P) in order to proliferate, differentiate, and present immune cell-activating antigens, according to a study in The Journal of Cell Biology.
Continuing to drive innovation in endovascular aortic repair (EVAR), Medtronic, Inc., today announced the introduction of an imaging and visualization service for endovascular specialists who use the company's market-leading portfolio of stent grafts to treat aortic aneurysms. Aortic aneurysms affect more than one million people in the United States alone and can rupture with fatal consequences if left untreated.
New research shows that exposing a 3D human skin tissue model to extracts of medical device materials can detect the presence of sensitizers known to cause an allergic response on contact in some individuals. Conventional skin sensitization testing of medical devices relies on animal testing, whereas human skin models could replace animal methods, according to an article in the new journal Applied In Vitro Toxicology, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
SeraCare Life Sciences, a leading partner to global in vitro diagnostics manufacturers, today announced that it has signed a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute, part of the National Institutes of Health, to create reference materials and positive controls for cancer assays.
BrainScope Company, Inc. announced today that it is preparing for the introduction of the Ahead™ EU-100, a product in development to aid in the assessment of head injury, in the United Kingdom.
› Verified 5 days ago
Dr. James Wesley Webb, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 630 Colonial Promenade Pkwy, Alabaster, AL 35007 Phone: 205-620-4697 Fax: 205-663-2217 | |
Alabaster Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 9200 Highway 119, Suite 600, Alabaster, AL 35007 Phone: 205-447-9379 | |
Dr. James Andrew Ho, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 300 1st St N, Alabaster, AL 35007 Phone: 205-949-2020 | |
Dr. Heather Mccall Webb, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 630 Colonial Promenade Pkwy, Alabaster, AL 35007 Phone: 205-663-2169 Fax: 205-663-2217 | |
Dr. Erin Raynaud Heckman, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1136 1st St N, Alabaster, AL 35007 Phone: 205-624-2500 Fax: 205-624-2502 | |
Melanie Chwalek, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 300 1st St N, Alabaster, AL 35007 Phone: 205-949-2020 Fax: 205-663-2015 | |
Shelby Family Eye Care, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 1136 1st St N, Alabaster, AL 35007 Phone: 205-624-2500 Fax: 205-624-2502 |